SGMO – sangamo therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Sangamo Therapeutics Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit, Improvements in Kidney Function and Favorable Safety Profile [Yahoo! Finance]
Sangamo Therapeutics Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease Showing Sustained Benefit, Improvements in Kidney Function and Favorable Safety Profile
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sangamo Therapeutics, Inc. - SGMO
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sangamo Therapeutics, Inc. - SGMO
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sangamo Therapeutics, Inc. - SGMO
Form 8-K SANGAMO THERAPEUTICS, For: Feb 06
Form 4 SANGAMO THERAPEUTICS, For: Jan 22 Filed by: Davis Gregory D
Form 4 SANGAMO THERAPEUTICS, For: Jan 22 Filed by: Willoughby Scott B.
Form 4 SANGAMO THERAPEUTICS, For: Jan 22 Filed by: Duraibabu Prathyusha
Form 4 SANGAMO THERAPEUTICS, For: Jan 22 Filed by: Dubois-Stringfellow Nathalie
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.